Find Research Outputs

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

Author

  • Robert B Livingston
2019

A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer

Segar, J. M., Reed, D., Stopeck, A. T., Livingston, R. B. & Chalasani, P., Jan 1 2019, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Open Access

Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer

Mehta, R. S., Barlow, W. E., Albain, K. S., Vandenberg, T. A., Dakhil, S. R., Tirumali, N. R., Lew, D. L., Hayes, D. F., Gralow, J. R., Linden, H. H., Livingston, R. B. & Hortobagyi, G. N., Mar 28 2019, In : New England Journal of Medicine. 380, 13, p. 1226-1234 9 p.

Research output: Contribution to journalArticle

16 Scopus citations
2018

Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci

Sucheston-Campbell, L. E., Clay-Gilmour, A. I., Barlow, W. E., Budd, G. T., Stram, D. O., Haiman, C. A., Sheng, X., Yan, L., Zirpoli, G., Yao, S., Jiang, C., Owzar, K., Hershman, D., Albain, K. S., Hayes, D. F., Moore, H. C., Hobday, T. J., Stewart, J. A., Rizvi, A., Isaacs, C. & 6 others, Salim, M., Gralow, J. R., Hortobagyi, G. N., Livingston, R. B., Kroetz, D. L. & Ambrosone, C. B., Jan 1 2018, In : Pharmacogenetics and Genomics. 28, 2, p. 49-55 7 p.

Research output: Contribution to journalArticle

7 Scopus citations
2016

Circulating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast Cancer

Brown-Glaberman, U., Marron, M., Chalasani, P., Livingston, R. B., Iannone, M. E., Specht, J. & Stopeck, A. T., 2016, In : Disease Markers. 2016, 9810383.

Research output: Contribution to journalArticle

7 Scopus citations

Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226

Hertz, D. L., Barlow, W. E., Kidwell, K. M., Albain, K. S., Vandenberg, T. A., Dakhil, S. R., Tirumali, N. R., Livingston, R. B., Gralow, J., Hayes, D. F., Hortobagyi, G. N., Mehta, R. S. & Rae, J. M., 2016, (Accepted/In press) In : British Journal of Clinical Pharmacology.

Research output: Contribution to journalArticle

10 Scopus citations

Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630

Potkul, R. K., Unger, J. M., Livingston, R. B., Crew, K. D., Wilczynski, S. P., Salomon, C. G., Smith, B. L., Wong, L., Campbell, D. L., Einspahr, D. E., Anderson, G. L., Hershman, D., Goodman, G. E., Brown, P. H., Meyskens, F. L. & Albain, K. S., Dec 14 2016, In : npj Breast Cancer. 2, 1, 16024.

Research output: Contribution to journalArticle

3 Scopus citations

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer

Nahleh, Z. A., Barlow, W. E., Hayes, D. F., Schott, A. F., Gralow, J. R., Sikov, W. M., Perez, E. A., Chennuru, S., Mirshahidi, H. R., Corso, S. W., Lew, D. L., Pusztai, L., Livingston, R. B. & Hortobagyi, G. N., Aug 1 2016, In : Breast Cancer Research and Treatment. 158, 3, p. 485-495 11 p.

Research output: Contribution to journalArticle

42 Scopus citations

Temporal heterogeneity of estrogen receptor expression in bone-dominant breast cancer: 18f-fluoroestradiol pet imaging shows return of er expression

Currin, E., Peterson, L. M., Schubert, E. K., Link, J. M., Krohn, K. A., Livingston, R. B., Mankoff, D. A. & Linden, H. M., Feb 1 2016, In : JNCCN Journal of the National Comprehensive Cancer Network. 14, 2, p. 144-147 4 p.

Research output: Contribution to journalArticle

5 Scopus citations
2015

Adjuvant Metronomic CMF in a Contemporary Breast Cancer Cohort: What's Old Is New

Cho, E., Schwemm, A. K., Rubinstein, L. M., Stevenson, P. A., Gooley, T. A., Ellis, G. K., Specht, J. M., Livingston, R. B., Linden, H. M. & Gadi, V. K., Oct 1 2015, In : Clinical Breast Cancer. 15, 5, p. e277-e285

Research output: Contribution to journalArticle

2 Scopus citations

A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer

Chalasani, P., Marron, M., Roe, D., Clarke, K., Iannone, M. E., Livingston, R. B., Shan, J. S. & Stopeck, A. T., Jul 1 2015, In : Cancer Medicine. 4, 7, p. 1051-1059 9 p.

Research output: Contribution to journalArticle

18 Scopus citations

Intravenous thiotepa for treatment of breast cancer-related leptomeningeal carcinomatosis: case series

Chahal, J., Stopeck, A. T., Clarke, K., Livingston, R. B. & Chalasani, P., Sep 27 2015, In : Neurological Sciences. 36, 9, p. 1691-1693 3 p.

Research output: Contribution to journalArticle

7 Scopus citations

SWOG S0221: A phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer

Budd, G. T., Barlow, W. E., Moore, H. C. F., Hobday, T. J., Stewart, J. A., Isaacs, C., Salim, M., Cho, J. K., Rinn, K. J., Albain, K. S., Chew, H. K., Burton, G. V., Moore, T. D., Srkalovic, G., McGregor, B. A., Flaherty, L. E., Livingston, R. B., Lew, D. L., Gralow, J. R. & Hortobagyi, G. N., Jan 1 2015, In : Journal of Clinical Oncology. 33, 1, p. 58-64 7 p.

Research output: Contribution to journalArticle

42 Scopus citations
2014

A phase II study of docetaxel and vinorelbine plus filgrastim for HER-2 negative, stage IV breast cancer: SWOG S0102

Gralow, J. R., Barlow, W. E., Lew, D., Dammann, K., Somlo, G., Rinn, K. J., Vogel, S. J., Wong, L., Livingston, R. B. & Hortobagyi, G. N., Jan 2014, In : Breast Cancer Research and Treatment. 143, 2, p. 351-358 8 p.

Research output: Contribution to journalArticle

11 Scopus citations

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500

Smerage, J. B., Barlow, W. E., Hortobagyi, G. N., Winer, E. P., Leyland-Jones, B., Srkalovic, G., Tejwani, S., Schott, A. F., O'Rourke, M. A., Lew, D. L., Doyle, G. V., Gralow, J. R., Livingston, R. B. & Hayes, D. F., Nov 1 2014, In : Journal of Clinical Oncology. 32, 31, p. 3483-3489 7 p.

Research output: Contribution to journalArticle

313 Scopus citations

Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer

Yao, S., Sucheston, L. E., Zhao, H., Barlow, W. E., Zirpoli, G., Liu, S., Moore, H. C. F., Thomas Budd, G., Hershman, D. L., Davis, W., Ciupak, G. L., Stewart, J. A., Isaacs, C., Hobday, T. J., Salim, M., Hortobagyi, G. N., Gralow, J. R., Livingston, R. B., Albain, K. S., Hayes, D. F. & 1 others, Ambrosone, C. B., 2014, In : Pharmacogenomics Journal. 14, 3, p. 241-247 7 p.

Research output: Contribution to journalArticle

11 Scopus citations
2013

Differential chemotherapeutic sensitivity for breast tumors with "BRCAness": A review

Chalasani, P. & Livingston, R. B., Aug 2013, In : Oncologist. 18, 8, p. 909-916 8 p.

Research output: Contribution to journalArticle

38 Scopus citations

Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole

Goss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Livingston, R. B., Davidson, N. E., Perez, E. A., Chavarri-Guerra, Y., Cameron, D. A., Pritchard, K. I., Whelan, T., Shepherd, L. E. & Tu, D., Feb 2013, In : Annals of Oncology. 24, 2, p. 355-361 7 p., mds330.

Research output: Contribution to journalArticle

58 Scopus citations

In vitro assessment of the inflammatory breast cancer cell line SUM 149: Discovery of 2 single nucleotidepolymorphisms in the Rnase L gene

Nokes, B. T., Cunliffe, H. E., LaFleur, B., Mount, D. W., Livingston, R. B., Futscher, B. W. & Lang, J. E., 2013, In : Journal of Cancer. 4, 2, p. 104-116 13 p.

Research output: Contribution to journalArticle

6 Scopus citations
2012

Combination anastrozole and fulvestrant in metastatic breast cancer

Mehta, R. S., Barlow, W. E., Albain, K. S., Vandenberg, T. A., Dakhil, S. R., Tirumali, N. R., Lew, D. L., Hayes, D. F., Gralow, J. R., Livingston, R. B. & Hortobagyi, G. N., Aug 2 2012, In : New England Journal of Medicine. 367, 5, p. 435-444 10 p.

Research output: Contribution to journalArticle

270 Scopus citations

Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patients

Kurland, B. F., Gadi, V. K., Specht, J. M., Allison, K. H., Livingston, R. B., Rodler, E. T., Peterson, L. M., Schubert, E. K., Chai, X., Mankoff, D. A. & Linden, H. M., 2012, In : EJNMMI Research. 2, 1

Research output: Contribution to journalArticle

22 Scopus citations

Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430

Schott, A. F., Barlow, W. E., Albain, K. S., Chew, H. K., L.Wade III, J., Lanier, K. S., Lew, D. L., Hayes, D. F., Gralow, J. R., Livingston, R. B. & Hortobagyi, G. N., 2012, In : Oncologist. 17, 2, p. 179-187 9 p.

Research output: Contribution to journalArticle

4 Scopus citations
2011

Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer

Linden, H. M., Kurland, B. F., Peterson, L. M., Schubert, E. K., Gralow, J. R., Specht, J. M., Ellis, G. K., Lawton, T. J., Livingston, R. B., Petra, P. H., Link, J. M., Krohn, K. A. & Mankoff, D. A., Jul 15 2011, In : Clinical Cancer Research. 17, 14, p. 4799-4805 7 p.

Research output: Contribution to journalArticle

75 Scopus citations

Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)

Sucheston, L. E., Zhao, H., Yao, S., Zirpoli, G., Liu, S., Barlow, W. E., Moore, H. C. F., Thomas Budd, G., Hershman, D. L., Davis, W., Ciupak, G. L., Stewart, J. A., Isaacs, C., Hobday, T. J., Salim, M., Hortobagyi, G. N., Gralow, J. R., Livingston, R. B., Albain, K. S., Hayes, D. F. & 1 others, Ambrosone, C. B., Dec 2011, In : Breast Cancer Research and Treatment. 130, 3, p. 993-1002 10 p.

Research output: Contribution to journalArticle

37 Scopus citations

Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial

Ganz, P. A., Land, S. R., Geyer, C. E., Cecchini, R. S., Costantino, J. P., Pajon, E. R., Fehrenbacher, L., Atkins, J. N., Polikoff, J. A., Vogel, V. G., Erban, J. K., Livingston, R. B., Perez, E. A., Mamounas, E. P., Wolmark, N. & Swain, S. M., Mar 20 2011, In : Journal of Clinical Oncology. 29, 9, p. 1110-1116 7 p.

Research output: Contribution to journalArticle

79 Scopus citations

PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: Value of static versus kinetic measures of fluorodeoxyglucose uptake

Dunnwald, L. K., Doot, R. K., Specht, J. M., Gralow, J. R., Ellis, G. K., Livingston, R. B., Linden, H. M., Gadi, V. K., Kurland, B. F., Schubert, E. K., Muzi, M. & Mankoff, D. A., Apr 15 2011, In : Clinical Cancer Research. 17, 8, p. 2400-2409 10 p.

Research output: Contribution to journalArticle

56 Scopus citations

Phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus granulocyte colony-stimulating factor as neoadjuvant therapy for inflammatory and locally advanced breast cancer: SWOG 0012

Ellis, G. K., Barlow, W. E., Gralow, J. R., Hortobagyi, G. N., Russell, C. A., Royce, M. E., Perez, E. A., Lew, D. & Livingston, R. B., Mar 10 2011, In : Journal of Clinical Oncology. 29, 8, p. 1014-1021 8 p.

Research output: Contribution to journalArticle

39 Scopus citations

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Aug 27 2011, In : The Lancet. 378, 9793, p. 771-784 14 p.

Research output: Contribution to journalArticle

1306 Scopus citations

SWOG S0215: A phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer

Livingston, R. B., Barlow, W. E., Kash, J. J., Albain, K. S., Gralow, J. R., Lew, D. L., Flaherty, L. E., Royce, M. E. & Hortobagyi, G. N., Nov 2011, In : Breast Cancer Research and Treatment. 130, 1, p. 123-131 9 p.

Research output: Contribution to journalArticle

3 Scopus citations

Systemic treatment of metastatic breast cancer

Downey, L. & Livingston, R. B., 2011, Breast Surgical Techniques and Interdisciplinary Management. Springer New York, p. 1039-1044 6 p.

Research output: Chapter in Book/Report/Conference proceedingChapter